Investing Profile

Anja Konig

VCInvestor
Global Head Novartis Venture Fund
nvfund.comBasel, Switzerland
Photo of Anja Konig, Managing Director at Novartis Venture Fund
cb
Novartis Venture Fund Managing Director
$5.0M - $10.0M
$7.5M
16
$750M
CompanyStageDateRound SizeTotal Raised
Forendo Pharma
Series UnknownJul 2019$6M
Series UnknownSep 2018$5M
Series AOct 2014$15M
$26M
Co-investors: Hakan Goker (M Ventures (Merck))
Bicycle Therapeutics
Series BJun 2017$52M
Series AOct 2014$32M
Series UnknownDec 2012$6M
SeedOct 2009
$90M
Co-investors: Deborah Harland (SR One), Bruce Booth (Atlas Venture), Dr. Regina Hodits (Wellington Partners)
F2G
Private EquityJun 2016$60M
Series UnknownSep 2012$30M
$160M
Co-investors: Maha Katabi (Sofinnova Investments), Raj Parekh (Advent Life Sciences), Nanna Luneborg (Forbion), Joseph Anderson (Soffinova Partners)
Nabriva Therapeutics
Series BApr 2015$120M
$120M
Covagen
Series BDec 2013$66M
Series ANov 2010$6M
SeedOct 2009
$72M
Co-investors: Abraham Kometz (Deerfield Management)
Oxagen
Series CNov 2009$27M
$27M
PharmAbcine
Series ASep 2009$6M
$6M
Diagnoplex
Series ADec 2008$8M
$9M
Co-investors: Thomas Goebel (Omega Funds)